SCHEMBL838150

SCHEMBL838150

N=C(Cc1ccc(O)cc1)NO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.46
CAMK2A Q9UQM7 1/20 0.46
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
FNTA P49354 1/20 0.42
FNTB P49356 1/20 0.42
ABAT P80404 1/20 0.41
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
AGER Q15109 1/20 0.38
CTBP2 P56545 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
SLC6A2 P23975 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTR3A P46098 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1965925 0.82 IDO1 (0.45) KDM4ETAAR1L3MBTL1IDO1NPC1
SCHEMBL1580990 0.80 IDO1 (0.44) CTBP2ALDH1A1L3MBTL1IDO1NPC1
SCHEMBL641565 0.80 GAA (0.46) CTBP2KDM4EALDH1A1IDO1RAB9A
SCHEMBL641405 0.80 IDO1 (0.44) CA2HDAC2HDAC8CTBP2ALDH1A1
SCHEMBL14286041 0.80 LMNA (0.49) CA2CAMK2AESR1ESR2FNTA
SCHEMBL23586287 0.80 ALDH1A1 (0.42) CA2HDAC8ALDH1A1IDO1
SCHEMBL480288 0.80 CYP3A4 (0.35) CA2HDAC8SIGMAR1IDO1
SCHEMBL434982 0.79 HDAC8 (0.56) HDAC2HDAC8ALDH1A1L3MBTL1IDO1
SCHEMBL21097010 0.77 LMNA (0.53) CA2HDAC2HDAC8ALDH1A1TAAR1
SCHEMBL23578295 0.77 POLB (0.46) CA2KDM4EALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2272848-B1 Xanthine derivatives as selective HM74A agonists GLAXOSMITHKLINE LLC (US) 2012-12-26 EP disclosed
US-8143264-B2 Xanthine derivatives as selective HM74A agonists GLAXOSMITHKLINE LLC (US) 2012-03-27 US disclosed
US-20110257205-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GLAXOSMITHKLINE LLC 2011-10-20 US disclosed
EP-2272848-A1 Xanthine derivatives as selective HM74A agonists Glaxosmithkline LLC (US) 2011-01-12 EP disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed
US-20100168122-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168122-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GPR84, XDH, GPR88 CA2 4037/4885CAMK2A 2771/4885ESR1 1362/4885
US-20110257205-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GPR84, GPR88, XDH CA2 4254/4885CAMK2A 2573/4885ESR1 1299/4885
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 CA2 3862/4885CAMK2A 2429/4885ESR1 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.